HTG Molecular Diagnostics, Inc. (HTGM) financial statements (2022 and earlier)

Company profile

Business Address 3430 E. GLOBAL LOOP
TUCSON, AZ 85706
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments21,94325,41729,75830,76628,69630,51732,867
Cash and cash equivalents9,60010,23013,57621,77822,39818,88421,014
Short-term investments12,34315,18816,1828,9886,29811,63211,852
Receivables2,0921,9051,4221,2501,5891,3701,011
Inventory, net of allowances, customer advances and progress billings1,9882,3412,3181,6031,4921,5391,389
Inventory1,9882,3412,3181,6031,4921,5391,389
Contract with customer, asset     42 
Other undisclosed current assets1,1632,0822,4491,5301,0949051,236
Total current assets:27,18731,74535,94735,14932,87134,37236,503
Noncurrent Assets
Operating lease, right-of-use asset1,3451,4442463491,009746905
Property, plant and equipment1,1191,2191,1211,1241,2271,5271,825
Other noncurrent assets8099966906569
Total noncurrent assets:3,2742,7621,3731,4792,3272,3382,800
TOTAL ASSETS:30,46134,50737,32036,62835,19836,71039,303
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,6722,7553,0002,4682,8092,2621,875
Accounts payable1,6491,1461,6821,3531,349875928
Accrued liabilities2,0231,6091,3181,1151,4601,387947
Deferred revenue125213209494185348419
Debt5,1684,1853,1834,5223,0222,2941,727
Asset retirement obligation548531486479513646864
Other liabilities17181920232731
Other undisclosed current liabilities414381245354685410 
Total current liabilities:9,9448,0827,1428,3377,2365,9864,916
Noncurrent Liabilities
Long-term debt and lease obligation6,1597,4007,4827,0908,9859,89011,159
Long-term debt, excluding current maturities5,1796,3097,4437,0478,5689,44710,705
Finance lease, liability313539434853 
Operating lease, liability9491,056  369390453
Liabilities, other than long-term debt3,9894,1734,2944,4044,5404,6854,544
Asset retirement obligations3,9014,0734,2454,3554,4794,4564,359
Other liabilities88100494960229185
Other undisclosed noncurrent liabilities(49)(73)(76)(43)(48)(75) 
Total noncurrent liabilities:10,10011,50011,70011,45113,47714,50015,703
Other undisclosed liabilities173837  22 
Total liabilities:20,06119,62018,87919,78820,71320,50920,619
Stockholders' equity
Stockholders' equity attributable to parent10,40014,88718,44116,84014,48516,20118,684
Preferred stock0000000
Common stock887657167
Additional paid in capital218,723218,019217,081212,866205,662203,021200,080
Accumulated other comprehensive income23445723
Accumulated deficit(208,333)(203,142)(198,651)(196,036)(191,188)(186,898)(181,486)
Total stockholders' equity:10,40014,88718,44116,84014,48516,20118,684
TOTAL LIABILITIES AND EQUITY:30,46134,50737,32036,62835,19836,71039,303

Income statement (P&L) ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Revenues2,8772,5202,0741,4352,5831,7771,963
Cost of revenue
(Cost of Goods and Services Sold)
(1,355)(984)(971)(785)(1,061)(941)(975)
Gross profit:1,5221,5371,1036501,522836989
Operating expenses(6,452)(5,767)(5,185)(5,232)(5,545)(6,008)(5,988)
Operating loss:(4,930)(4,230)(4,082)(4,582)(4,023)(5,172)(5,000)
Nonoperating income (expense)(260)(258)1,483(264)(265)(239)(705)
Interest and debt expense(267)(267)(260)(270) (273)(522)
Loss from continuing operations before equity method investments, income taxes:(5,457)(4,755)(2,859)(5,116)(4,288)(5,684)(6,227)
Other undisclosed income from continuing operations before income taxes267267260270 273522
Loss from continuing operations before income taxes:(5,189)(4,489)(2,599)(4,846)(4,288)(5,410)(5,705)
Income tax expense(2)(2)(16)(2)(2)(2)(6)
Net loss available to common stockholders, diluted:(5,191)(4,491)(2,615)(4,848)(4,290)(5,412)(5,711)

Comprehensive Income ($ in thousands)

12/31/2021
Q4
9/30/2021
Q3
6/30/2021
Q2
3/31/2021
Q1
12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
Net loss:(5,191)(4,491)(2,615)(4,848)(4,290)(5,412)(5,711)
Other comprehensive loss(1)(1)(0)(2)(1)(16)(25)
Comprehensive loss, net of tax, attributable to parent:(5,192)(4,492)(2,615)(4,850)(4,291)(5,428)(5,736)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: